ThermoGenesis Holdings to Announce Financial Results for the Second Quarter Ended June 30, 2020 and Provide a Corporate Strategic Update

Rhea-AI Summary

ThermoGenesis Holdings, Inc. (Nasdaq: THMO) will release its financial results for the second quarter ended June 30, 2020, and provide a corporate strategic update on August 12, 2020, after market close. A conference call is scheduled for 1:30 p.m. PT / 4:30 p.m. ET. Investors can participate by dialing domestic and international numbers or access a live webcast. The company specializes in automated technologies for CAR-T and cell-based therapies, focusing on solutions for clinical biobanking and immuno-oncology.

Positive

• Upcoming financial results release for Q2 2020 highlights transparency.
• Strategic update may indicate positive developments in CAR-T technology.

Negative

• None.

RANCHO CORDOVA, Calif., Aug. 5, 2020 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the second quarter ended June 30, 2020 and provide a corporate strategic update on Wednesday, August 12, 2020 after the close of trading.  A conference call and webcast will follow at 1:30 p.m. PT/ 4:30 p.m. ET.

To participate in the conference call, please dial 1-844-889-4331 (domestic), 1-412-380-7406 (international) or 1-866-605-3852 (Canada). To access a live webcast of the call, please visit: https://thermogenesis.com/investors/news-and-events/events-webcasts.

A webcast replay will be available on ThermoGenesis' website for three months by visiting the Investor page of the Company's website at www.thermogenesis.com.

About ThermoGenesis Holdings, Inc.
ThermoGenesis Holdings, Inc. develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress™ platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. For more information about ThermoGenesis, please visit: www.thermogenesis.com.

Company Contact:
Wendy Samford
916-858-5191
ir@ThermoGenesis.com

Investor Contact:
Paula Schwartz, Rx Communications
917-322-2216
pschwartz@rxir.com

View original content:http://www.prnewswire.com/news-releases/thermogenesis-holdings-to-announce-financial-results-for-the-second-quarter-ended-june-30-2020-and-provide-a-corporate-strategic-update-301106426.html

SOURCE ThermoGenesis Holdings, Inc.

FAQ

When will ThermoGenesis announce its Q2 2020 financial results?

ThermoGenesis will announce its Q2 2020 financial results on August 12, 2020.

What is the significance of the August 12 announcement for THMO?

The August 12 announcement will provide insights into ThermoGenesis' financial health and strategic direction.

How can I access the ThermoGenesis earnings call?

You can participate in the earnings call by dialing provided numbers or via the live webcast on ThermoGenesis' investor page.

What technologies does ThermoGenesis focus on?

ThermoGenesis focuses on automated technologies for CAR-T and other cell-based therapies.